Artikelen

This reading list we received from Drs entirely disinterested. E. Valstar, (Orthomolecular) doctor / biologist. We provide this list are unchanged for publication. .

Scroll down for list.

Valstar wrote the book Nutritional intervention in cancer, a signal to the conventional oncology. See description on page, etc. ISBN cancer rates. We want to mention that we have no business or substantive ties with Engelbert Valstar, but this book and lists seem to us so interesting that we want to change places. Questions / comments can be sent to the editor: redactie@kanker-actueel.nl We will keep your questions / comments to be forwarded Valstar. Also on this list and further information on this page is of course our disclaimer applies.

More detailed descriptions and other studies see and nutrition research. And we try to at least the abstract and the results of the Phase III trials and pivotal Phase II studies in the literature list and nutrition research. or current mainstream research to publish or not fitted comments.

For regular treatments in general because the only randomized study possible side effects. Moreover, a randomized study of conventional treatments often never implemented. This assertion of Valstar based on relevant literature is in NTvG (see NTvG 136: 709-710, 1992) by the respective oncologists not contradicted.
See also Nutritional Oncology, Heber D. et al ISBN 0-12-335960-0, the book was edited by Harvard and by the Memorial Sloan Kettering Institute! ).
(Editors note: See extensive bibliography in the book of Valstar Nutritional intervention in cancer, a signal to the conventional oncology and now as published on this site)..

To this list are Hans Houtsmuller, Ed Woerlee Johan Bolhuis and important contributions.

Bibliography of studies cancer and nutrition / supplementation. Studies: 101 t / m 200

101) Smyth JF et al, Ann Oncol 8: 569-73, 1997; glutathione reduces randomized, double-blind study, the side effects of cisplatin in patients with ovarian cancer, the findings in the references 95,98,100 and 101 are such that a meta- regression analysis regarding the likelihood of a tumor when glutathione is also given an interesting question is.

102) S Motomura et al, Am J Hematol 38: 67-8, 1991. The precursor of vitamin D 3: 1-alpha-25-hydroxyvitamin D3 significantly slows the transition of malignancy myelodysplastic syndrome (this alone, people can die) to the much malignere leukemia.

103) Wagdi P et al, Jpn Heart J 37: 353-9; 1996.Vitamin E plus C plus NAC reduced in this randomized double-blind study irreversible effects on the heart by chemotherapy

104) and UN Sukulinskii Morozkina TS, Vopr Onkol 35: 1242-5, 1989. Supplementation with vitamins A, C and E decreases in operations associated with stomach cancer the number of postoperative complications significantly (dropping from 30.9 to 1.9%), it was a randomized trial in 197 patients.

105) Agteresh HJ et al, Clin Sci 98: 689-95, 2000. ATP (adenosine triphosphate) is randomized study (12 patients), infused the extreme emaciation of patients with non-small cell lung cancer against.

106) Agteresh HJ et al, JNCI 92: 321-8, 2000, in a randomized trial in 58 patients with non small cell lung cancer stage 3B or 4 ATP reduced the reduction of muscle strength and partly because it improved the quality of life of patients. Animal studies also found that ATP is the result of radiation and chemotherapy can improve (Agteresh HJ et al, Drugs 58: 211-32, 1999).

107) K. Hayakawa et al, Cancer Detect Prev 21: 71-7, 1997; PSK improves survival 5 years of patients with lung cancer in randomized studies significantly.

108) Masuno T et al, Cancer 68: 1495-500, 1991, with a lactic acid bacterium extract appears in a randomized design with doxorubicin in lung cancer patients significantly more often a regression to act than with doxorubicin alone and shows the lactic acid bacteria group, the survival demonstrably longer.

109) Israel L et al, Ann Internal Med 136: 551-4, 1985, vitamin A increases risk of chemotherapy response in postmenopausal women, duration of response to chemotherapy and improves survival.

110) Hu YJ et al, Biol Trace Elem Res 56: 331-41, 1997; nephrotoxiciteit selenium reduces the number of leucopenia and also the blood transfusions in patients treated with cisplatin.

111) Li J et al, Zhongguo Zhong Xi Yi Jie He sat Zhi 18: 523-6, 1998; The Fuzheng Baozhen extract in a randomized trial improves the likelihood of chemotherapy response and / or radiotherapy, but survival, especially the latter is statistically hard.

112) Salim AS; Chemotherapy 38: 135-44, 1992; DMSO, another natural substance improves adjuvant randomized study of the 5-year survival in gastric cancer patients.

113) Salim AS; Chemotherapy 38: 127-34, 1992: DMSO, another natural substance improves adjuvant randomized study of the 5-year survival for curative principle in cancer patients.

114) Salim AS, Tumor Biol 14: 9-17, 1993, DMSO, another natural substance, increases in reported cancer patients according to randomized trials of life.

115) Vernia P et al; Butyric shown in a randomized double-blind study effective against bestralingsproctitis, Lancet 356: 1232-5, 2000.

116) Johnston B., Cancer Chemotherapy Reports 21: 19-68, 1962: The Coley vaccine provides cancer patients was significantly higher than clinically relevant improvements in the control of this randomized study with a placebo treatment occurs (in the experimental group, the tumor in September smaller of the 34 patients, while in the control group of 37 patients this was not observed at all).

117) Fujimoto S et al; Ryoho Gan To 10 :1135-45, 1983; Schizophyllan (SPG) improves survival in randomized studies of patients operated due to gastric cancer.

118) Nakao I et al; Gan To Kagaku Ryoho 10: 1146-1159, 1983; Schizophyllan (SPG) improves survival in randomized studies in patients with relapsed gastric cancer an d it with an inoperable stomach cancer.

119) Lissoni P et al, Neuroendocrinol Lett 21: 319-23, 2000: The natural nutrient methoxytryptamine shows melatonin in patients who already have demonstrated tumor progression additional braking.

120) Mayne ST et al, Cancer Res 61: 1457-1463, 2001, beta-carotene shows the risk of recurrence in patients treated for throat cancer in a randomized double-blind study not decrease (becoming clear that carotene is much less important than was adopted, a form of vitamin A acid and lycopene in the vitamin A-like substances of most interest.

121) Lissoni P et al, Treatment of Tumors 79: 202-4, 1993, L-carnitine reduces randomized study the risk of cardiac complications in patients treated with interleukin.

122) Lissoni P et al, Eur J Cancer 35: 1688-1692, 1999, in a large randomized trial of different types of metastatic cancer shows melatonin side effects of conventional therapy to reduce and improve survival.

123) H. Nakano et al, Hepatogastroenterology 46: 2662-8, 1999, lentinan enhances in gastric cancer patients with an advanced form of stomach cancer in a randomized study the quality of life and prolong it.

124) K Tari et al, Hinyokika Kiyo 40: 119-23, 1994; lentinan (Shiitake) improves randomized in prostate cancer patients taking hormonal therapy, the 5-year survival.

125) Taguchi T et al; Gan To Kagaku Ryoho 12: 366-78, 1985, lentinan (Shiitake) extends randomized study the life of gastric cancer patients in an advanced stage or where the disease has returned, in patients with an advanced form of colon cancer seem beneficial effects of lentinan, but is hard enough and other statistical.

126) Taguchi T, Gan To Kagaku Ryoho 10: 387-93, 1983; lentinan (Shiitake) prolongs life in randomized studies in patients with advanced or recurrent stomach, colon or breast cancer.

127) Akimoto M et al; Gan To Kagaku Ryoho 13: 1270-6, 1986; lentinan prolonged in this randomized study the lives of patients with an advanced form of stomach cancer, but only if the nutritional status is still somewhat reasonable.

128) Nishihira T et al; Gan To Kagaku Ryoho 15: 1615-20, 1988, this study is similar to reference 127 and reached the same conclusion.

129) Meyskens FL et al, J Clin Oncol 12: 2060-5, 1994, Vitamin A in a dose of 100,000 IU per day seems just as adjuvants in the treatment of malignant melanoma, the treatment does not improve outcome.

130) Agter Esch HJ et al, J Clin Oncol 20: 371-8, 2002, ATP is in patients with non-small cell lung cancer in a randomized trial loss of appetite and weight against.

131) Guo XM et al, Zhongguo Zhong Xi Yi Jie He Za Zhi 17: 325-7, 1997, in a randomized trial in patients with non-Hodgkin's lymphoma was Chinese herbs plus chemotherapy improved survival than with chemotherapy alone found .

132) Gansauge F et al, Arch Surg 386 Long Becks: 570-4, 2002; Ukrain prolongs in this randomized study in patients with pancreatic cancer life.

133) Urbancsek H et al, Eur J Gastroenterol Hepatol 13: 391-6, 2001, Lactic acid bacteria reduce this randomized study the side effects of radiotherapy in the abdominal area.

134) Susak YM et al, Drugs Exp Clin Res 22: 115-22, 1996, in patients with colorectal cancer appears to improve Ukrain prognosis more than 5-FU and radiation combined power (without 5-FU and leucovorin to improve radiation together prognosis barely).

135) VS Zemskov et al, Drugs Exp Clin Res, 26: 179-90, 2000, Ukrain also prolongs the life of this randomized study of patients with pancreatic cancer.

136) Hattori T et al, Jpn J Surg 20 :127-136, 1990; PSK shown in randomized studies using immuno-stimulation, the prognosis of gastric cancer to improve.

137) HM Huang and Long H. Zhongguo Zhong Xi Yi Jie He Za Zhi 17: 26-8, 1997, in advanced lung cancer risk found by the regression Chinese herbs to enhance chemotherapy and life will be extended by additional herbs.

138) and Lin HZ Wang ZT, Zhongguo Zhong Xi Yi Jie He Za Zhi 17: 730-2, 1997; randomized study improves kang 'aiboa = kabol the oral cancer survival significantly.

139) Guo Z, Zhongguo Zhong Xi Yi Jie He Za Zhi 19: 20-2, 1999; Fuzheng yiai-drink improves survival of cancer patients who receive chemotherapy as adjuvant.

140) Hua B, Wang A, Zhongguo Zhong Xi Yi Jie He Za Zhi 19: 470-2, 1999; Xiansu disease in patients with gastric cancer and the side effects of chemotherapy in this study increased the likelihood of chemotherapy response from 13.3 to 32 , 8 percent.

141) Xin M et al, Zhongguo Zhong Xi Yi Jie Za Zhi 18: 658-61, 1998, patients with gastrointestinal cancer undergoing chemotherapy plus Shenqi Fuzheng get, do better than patients who receive chemotherapy alone: ​​more and better quality regressions of life.

142) Yang D et al, Zhonghua Wai Ke Za Zhi 37: 464-71, 1999. Zhuling in this randomized study also reduces the risk of recurrence of bladder cancer, it works just as well as significantly better than BCG and mitomycin C or do anything extra.

143) Chen S et al, Zhonghua Zhong Liu Za Zhi 19: 228-30, 1997; Nocardia rubra works as adjuvants in the treatment of bladder cancer according to randomized trials as good as mitomycin C

144) FR Douwes et al, Zeitschrift fur Onkologie 18: 155-62, 1986; Mistletoe (Iscador), but also give Neytumorin life extension in randomized studies in patients with metastatic colon cancer.

145) Kojima J et al; Gan To Kagaku Ryoho 14: 179-87, 1987; PSK improves survival in randomized studies of patients with primary liver cancer.

146) Toge T et al, Oncol Rep 7: 1157-1161, 2000; PSK appears again in case of stomach cancer in randomized studies to improve the prognosis.

147) Isenberg J et al, Anticancer Res 17 (5B): 3767-72, 1997, D-galactose inhibits randomized study in patients with colorectal cancer metastases to the liver significantly.

148) J. Kosik et al, Anticancer Res 17 (2B): 1411-5, 1997, D-galactose shown in randomized studies in cases of stomach cancer metastasis to the liver to inhibit such a way that would cause the survival improves.

149) Warczynski P et al, Anticancer Res 17 (2B): 1223-6, 1997, by D-galactose inhibits in cancer metastasis to the liver and improves survival.

150) Daniele B et al, Gut 48: 28-33, 2001, glutamine significantly reduces randomized study the effects on the intestine.

151) Nobile MT et al, Eur J Cancer 28A (11): 1823-7, 1992, with only a weekly 5-FU leucovorin also gives a greater chance of response, in this small randomized study, the time without disease progression as not significant longer in the leucovoringroep.

152) Sanchiz Milla F and A, Eur J Cancer 32A (1): 52-6, 1996: Thymostimuline reduces randomized study the number of infections during chemotherapy.

153) Alba E et al, Minerva Gineacol 43: 585-7, 1991: results confirmed number 152.

154) Periti P et al, J Chemother 5: 37-42, 1993; Thymostimuline decreases in case of surgery for colorectal cancer, the number of postoperative infections significantly.

155) Lissoni P et al, Eur Urol 2000 38: 115-8, 2000, Melatonin prolongs life in patients with advanced kidney cancer.

156) Kaul R et al, in patients with throat cancer reduces Wobe Mugos-randomized study, the side effects of radiotherapy is very clear.

157) and UN Sukolinskii Morozkina TS, Vopr Onkol 35: 1242-5, 1989, the combination of vitamins A, C and E decreases in stomach cancer surgery because of the number of postoperative complications from 31 to 2% (total 197 patients).

158) Fujisawa T, Yamaguchi Y, Cancer 78: 1892-8, 1996: Nocardia rubra as adjuvant after surgery improves survival of patients with lung cancer stage 1.

159) Kasse Roller RG and GN Schrauzer, J. Am Ther 7: 273-9, 2000; sodium plus lymph drainage reduces arm edema in breast cancer patients according to randomized double-blind study over lymphatic drainage alone.

160) PM Andersen et al, Cancer 83: 1433-9, 1998; glutamine reduces stomatitis by chemotherapy in randomized double-blind study.

161) Lissoni P et al; Support Care Cancer 5: 126-9, 1997; melatonin reduces randomized study demonstrated thrombocytopenia and depression through chemo, stomatitis and neuropathy were also less in the melatonin group, though the benefit is not significant.

162) C Decker-Baumann et al, Eur J Cancer 35: 202-7, 1999; glutamine disease in patients with metastatic colorectal cancer, with 5-FU and leucovorin treatment, inflammation and ulcers in the stomach and duodenum.

163) Menander-Huber KB, Urol Res 6: 255-7, 1978, copper-zinc dismutase reduces randomized double-blind study the effects of radiotherapy in patients irradiated for bladder cancer.

164) Edsmyr F, Menander-Huber KB, Eur J Rheumatol Inflamm 4: 228-36, 1981, copper-zinc dismutase reduces randomized double-blind study the effects of radiotherapy in patients with bladder and / or prostate cancer significantly.

165) Sanchiz F et al, Anticancer Res 16 (4A): 2025-8, 1996, copper-zinc dismutase reduces this large-scale randomized study of the serious side effects of radiotherapy for bladder cancer patients.

166) Tu Q et al; Hunan Yi Ke Da Xue Xue Bao 23: 308-10, 1998, Superoxide dismutase, reduced in this randomized double-blind study the effects of radiation in a mixed group of cancer patients.

167) received S et al; Urologists A 41: 164-8, 2002, AF-2 decreases in cases of chemotherapy for urothelial cancer, gastrointestinal side effects detectable, bone marrow toxicity, with AF-2 less, but this was not reached statistical significance.

168) Isenberg J et al, Anticancer Res 15: 2363-8, 1995, Propionibacterium avidum KP-40 improved randomized study in stage 1 and 2, the survival of patients with colorectal cancer, also improved the quality of life.

169) May PE et al, Am J Surg 183: 471-9, 2002, the combination of arginine, glutamine and beta-hydroxy beta-methylbutyrate is randomized double-blind study in patients with advanced cancer loss of lean body mass against.

170) Bozzetti F et al, Nutrition 13: 748-51, 1997, in a randomized double-blind study in patients with breast cancer showed glutamine diarrhea by chemotherapeutic doxifluridine not be prevented.

171) Coghlin D et al; pling 24: 61-6, 2000, glutamine has no effect in randomized studies on the development of mucositis associated with bone marrow transplantation.

172) Agarwala SS et al, J Clin Oncol 20: 125-33, 2002, Histamine randomized study extends the life of melanoma patients, which are treated with interleukin 2.

173) Mitomi T et al; Gan To Kagaku Ryoho 16: 2241-9, 1989; PSK increases the cure rate of patients operated due to colorectal carcinoma.

174) Schulof RS et al, J Biol Response Mod 4: 147-58, 1985, in a double-blind study in patients with non-small cell lung cancer treated with radiation, thymosin-alpha 1 was able to radiation-related immunosuppression to eliminate and also gave it a longer disease-free survival and a better survival sec.

175) Sallan SE, et al, N Engl J Med 293: 795-7, 1975, in double-blind study shows delta-9-tetrahydrocannibol vomiting associated with chemotherapy reduction.

176) Inoue M et al, Biotherapy 6: 13-8, 1993, SPG improves randomized study the long-term prognosis of ovarian cancer.

177) K. Noda et al, Jpn J Clin Oncol 22: 17-25, 1992, SPG increased in patients with cervical cancer stage 2 or 3 the regression likelihood by radiotherapy.

178) K. Okamura et al, Biotherapy 1: 103-7, 1989, SPG disease in patients with cervical cancer stage 2 / 3 the risk of recurrence and improves survival, further analysis showed that the benefit came mainly from stage 2 patients.

179) H. Furue et al, Gan To Kagaku Ryoho 12: 1272-7, 1985, SPG randomized study extends the life of incurable gastric cancer patients treated with mitomycin C plus 5-FU and Tegafur treatment.

180) Huang EY et al, Int J Oncol Biol Phys Radiate 46: 535-9, 2000; glutamine disease in patients with throat cancer in randomized study the risk of radiation mucositis.

181) Quan D et al; Zhong Xi Yi Jie Za Zhi 19: 392-4, 1999, Traditional Chinese Medicine (TCM) prolongs survival in randomized studies of patients with brain metastases due to chemotherapy or radiotherapy treatment.

182) Miyazaki K et al, Gynecol Oncol 56: 412-20, 1995, SPG randomized study improves the 5-year survival of cervixcarcinoompatiënten stadium1B-4.

183) Lissoni P et al, Anticancer Res 10: 1759-1761, 1990; Melatonin is depression and hypotension as side effects of interleukin-2 in patients with metastatic kidney cancer to (it should be remembered that hypotension when treated with interleukin-2 basically a life-threatening side effect).

184) Fujimoto S et al, Eur J Cancer 27: 1114-8, 1991, SPG reduces in principle to curative surgery and chemotherapy in curing gastric cancer patients the risk of recurrence and improves survival five years.

185) Bondar GV et al, Drugs Exp Clin Res 24: 221-6, 1998; Ukrain appears in rectal cancer randomized study a stronger antitumor effect than the combination of radiation and 5-FU.

186) Sakamoto J et al, Surg Today 22: 530-6, 1992; PSK improved in this randomized studies, in principle, curatively treated gastric cancer patients disease-free survival, in subgroup analysis showed then that the advantage is entirely or almost entirely limited to patients with weakened immune system.

187) Nayel H et al, Nutrition 8: 13-8, 1992; A protein supplement is of high quality radiotherapy for throat cancer at break: the supplementation because less mucositis and improved fitness.

188) H. Nakano et al, Hepatogastroenterology 46: 2662-8; lentinan enhances survival in randomized studies of patients with relapsed / metastatic gastric cancer.

189) K Tari et al, Hinyokika Kiyo 40: 119-23, 1994; lentinan enhances randomized study the long-term survival of prostate cancer patients with poor prognosis significantly.

190) Lissoni P et al; Support Care Cancer 4: 313-6, 1996, Melatonin is both hypotension by interleukin 2 and TNF against.

191) Ikeda T et al; Gan To Ryoho 13: 1044-9, 1986; PSK improves survival in 5 years operated lung cancer patients by 20% (55.9 vs. 34.7%).

192) HJ Li, Zhongguo Zhong Xi Yi Jie Za Zhi 16: 136-8, 1996, TCM (Traditional Chinese Medicine) prolongs life of cancer patients treated with chemotherapy.

193) Xu X et al, Zhonghua Zhong Liu Za Zhi 20: 394-5, 1998; Patients with advanced cancer were randomized based on radiation alone or radiation with Chinese herbs, the latter group did demonstrate: a better response, a longer remission duration, a better median and 1-year survival improved.

194) JH Cheng, Zhonghua Zhong Xi Yi Jie He Za Zhi 14: 331-3, 323; Chinese herbs reduce nephrotoxicity of cisplatin in randomized studies.

195) Wang H, Zhongguo Zhong Xi Yi Jie Za Zhi 18: 411-3, 1998, Chinese herbs to improve survival in randomized studies of patients with primary liver cancer.

196) Fujimoto S, Nippon Geka Gakkai Zasshi 90: 1447-1450, 1989, SPG extends life of inoperable stomach cancer patients in randomized studies, in operable patients, survival was better with only stage 3 SPG.

197) Nakajima T et al; Gan To Kagaku Ryoho 12: 1850-1863, 1985; PSK improves survival in gastric cancer patients in a large randomized study.

198) Hi Sher et al, Cancer Res 48: 1663-1670, 1988; Thymostimuline shown in patients with small cell lung cancer who receive chemotherapy and radiation do not result in randomized studies to improve in another study of this list was the life in patients with poor thymus by substance or lengthened if there was not irradiated and in yet another study, the results at higher radiation doses without also positive, possible in this study there were few people with poor thymus. A (re) analysis of three studies together is necessary.

199) Taguchi T et al; Gan To Kagaku Ryoho 22: 753-64, 1995, a mixture of amino acids, which is methioninearm potentiates 5-FU, ie to act more regressions, the amino acid mixture did not enhance the chance of side effects.

200) GT Wang, Zhong Xi Yi Jie He Za Zhi 10: 712-6, 707, 1990, Chinese herbs as an adjuvant to improve the survival of gastric cancer patients, which in principle curative surgery.